These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37347738)

  • 1. Effects of COVID-19 disease on PAI-1 antigen and haematological parameters during disease management: A prospective cross-sectional study in a regional Hospital in Ghana.
    Nkansah C; Owusu M; Appiah SK; Mensah K; Bani SB; Osei-Boakye F; Agyemang LD; Ackah EB; Abbam G; Daud S; Quansah Y; Derigubah CA; Apodola FA; Ayangba V; Afrifa DA; Eshun CP; Iddrisu AW; Mintaah S; Twum B; Mohammed A; Agyare EM; Gyasi WA; Agbadza PE; Wilson CAE; Anane S; Antwi P; Antwi RAY
    PLOS Glob Public Health; 2023; 3(6):e0001866. PubMed ID: 37347738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen Activator Inhibitor-1 in poorly controlled vs well controlled Type-2 Diabetes Mellitus patients: A case-control study in a district hospital in Ghana.
    Nkansah C; Addai-Mensah O; Mensah K; Owusu M; Ephraim RKD; Adu P; Osei-Boakye F; Appiah SK; Serwaa D; Derigubah CA; Debrah AY
    PLoS One; 2021; 16(4):e0250090. PubMed ID: 33857223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating immunohaematological profile among COVID-19 active infection and recovered patients in Ghana.
    Konlaan Y; Asamoah Sakyi S; Kumi Asare K; Amoah Barnie P; Opoku S; Nakotey GK; Victor Nuvor S; Amoani B
    PLoS One; 2022; 17(9):e0273969. PubMed ID: 36094915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen activator inhibitor-1 levels as an indicator of severity and mortality for COVID-19.
    Baycan OF; Barman HA; Bolen F; Atici A; Erman H; Korkmaz R; Calim M; Atalay B; Aciksari G; Cekmen MB; Vahaboglu H; Caliskan M
    North Clin Istanb; 2023; 10(1):1-9. PubMed ID: 36910430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Critical Analysis of the Automated Hematology Assessment in Pregnant Women at Low and at High Altitude: Association between Red Blood Cells, Platelet Parameters, and Iron Status.
    Figueroa-Mujica R; Ccahuantico LA; Ccorahua-Rios MS; Sanchez-Huaman JJ; Vásquez-Velasquez C; Ponce-Huarancca JM; Rozas-Gamarra RE; Gonzales GF
    Life (Basel); 2022 May; 12(5):. PubMed ID: 35629394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haematological Parameters And Outcome In Hospitalized Patients With Covid-19: A Developing Country Experience.
    Iftikhar R; Kamran SM; Mirza ZE; Naseem A; Ali Shah SA; Riaz S; Fazal I; Alamgir W; Saeed F; Saleem S; Ali RS; Chaudhry QUN
    J Ayub Med Coll Abbottabad; 2021; 33(3):416-424. PubMed ID: 34487649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection.
    Francischetti IMB; Toomer K; Zhang Y; Jani J; Siddiqui Z; Brotman DJ; Hooper JE; Kickler TS
    EClinicalMedicine; 2021 Sep; 39():101069. PubMed ID: 34377969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial.
    Chowdhury FR; Hoque A; Chowdhury FUH; Amin MR; Rahim A; Rahman MM; Yasmin R; Amin MR; Miah MT; Kalam MA; Rahman MS
    Trials; 2020 Oct; 21(1):883. PubMed ID: 33106167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet function and fibrinolytic activity in patients with bronchial asthma.
    Tutluoglu B; Gurel CB; Ozdas SB; Musellim B; Erturan S; Anakkaya AN; Kilinc G; Ulutin T
    Clin Appl Thromb Hemost; 2005 Jan; 11(1):77-81. PubMed ID: 15678276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis.
    Yener S; Akarsu M; Demir T; Akinci B; Sagol O; Bayraktar F; Ozcan MA; Tankurt E; Yesil S
    J Endocrinol Invest; 2007 Nov; 30(10):810-9. PubMed ID: 18075282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease.
    Brandtzaeg P; Joø GB; Brusletto B; Kierulf P
    Thromb Res; 1990 Jan; 57(2):271-8. PubMed ID: 2315889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.
    Nguyen G; Horellou MH; Kruithof EK; Conard J; Samama MM
    Blood; 1988 Aug; 72(2):601-5. PubMed ID: 3135860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of TNF alpha inhibition on plasma fibrinolytic balance in patients with chronic inflammatory rheumatical disorders.
    Agirbasli M; Inanc N; Baykan OA; Direskeneli H
    Clin Exp Rheumatol; 2006; 24(5):580-3. PubMed ID: 17181930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral artery disease in type 2 diabetes: the role of fibrinolysis.
    Lapolla A; Piarulli F; Sartore G; Rossetti C; Martano L; Carraro P; De Paoli M; Fedele D
    Thromb Haemost; 2003 Jan; 89(1):91-6. PubMed ID: 12540958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing pregnancy-specific haematological reference intervals in Ghana; a three-center cross-sectional study.
    Simpong NL; Afefa CT; Yimpuri L; Akum B; Safo A; Edziah SJ; Simpong DL; Adu P
    PLoS One; 2023; 18(2):e0274422. PubMed ID: 36735666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of glycemic control in type 2 diabetes mellitus (T2DM) and its association with markers of coagulation and inhibitors of fibrinolysis: A case-control study in the Upper West Region, Ghana.
    Selleh PK; Anto EO; Boadu WIO; Sackey B; Boateng LA; Nkansah C; Nsafoah F; Saasi AR; Mintaah S; Wiafe YA; Derigubah C; Korsah EE; Frimpong J; Ansah E; Tamakloe VCKT; Adu P; Boachie J; Addai-Mensah O
    Health Sci Rep; 2023 Jun; 6(6):e1297. PubMed ID: 37292102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.